Multisensory Physical Exercises in People With Cognitive Impairment

Universidad Rey Juan Carlos25 enrolled

Overview

The main objective of the study is to evaluate the efficacy of a combined training program of physical exercise and multisensory stimulation (Physiocognitive Integration) in people with mild/moderate cognitive impairment.

Alzheimer's disease and other dementias are the main cause of cognitive impairment, with a prevalence of 0.4% worldwide and 1.23 in Europe. The WHO estimates that the growth of people with cognitive impairment to some degree will increase in the coming years, exceeding 75 million people in the world in 2030, and 135 million in 2050. The prevention of cognitive deterioration is mainly based on the implementation of non-pharmacological therapies. Multisensory stimulation is a non-pharmacological therapy that has benefits in patients with cognitive impairment, producing an improvement in cognitive function. Physical exercise is associated with a lower risk of onset of cognitive impairment and less cognitive impairment as well as a slower progression in people with mild cognitive impairment and in mild-stage dementias. In addition to the cognitive sphere, the positive effect of physical exercise in preventing falls has been widely studied. The main objective of the study is to evaluate the efficacy of a combined training program of physical exercise and multisensory stimulation (Physiocognitive Integration) in people with mild/moderate cognitive impairment. In order to do this, a experimental group will perform 20 sessions of multisensory training in addition to their current therapy and a second, control group, only their current therapy. Before and after the time need to complete the 20 sessions, all subjects were perform a battery of motor and cognitive tasks.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Dementia

Interventions

Cognitive therapyOTHER

Cognitive therapy

Physiocognitive IntegrationBEHAVIORAL

Physiocognitive Integration

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Absence of treatment with psychotropic drugs or stable dose of the same (without drug or dose modifications in the last four weeks). In the case of subjects who are part of the intervention group, the following will also be inclusion criteria: * Caregiver or family member who presents the appropriate skills for collaboration in the implementation of the exercises and in the management of the mobile application. * Availability of the necessary time for the initial training in the handling of the devices, the development of the sessions and the communication with the researchers. Exclusion Criteria: * Insufficient physical condition for participation. * Sensory deficits that make participation difficult. * Unstable clinical situation. * Unstable mental disorder or not adequately controlled with medication (depression, agitation, etc.). * Presence of associated pathology that involves treatment with drugs that alter cognitive abilities or interfere with the user's participation.

Locations (1)

Universidad Rey Juan Carlos

Fuenlabrada, Madrid, Spain

Outcomes

Primary Outcomes

Speed of Gait at preferred pace

Variables: Speed (m/s)

Time frame: baseline

Speed of Gait at preferred pace

Variables: Speed (m/s)

Time frame: at week 8

Cadence of Gait at preferred pace

Variables: cadence (steps/min)

Time frame: baseline

Cadence of Gait at preferred pace

Variables: cadence (steps/min)

Time frame: at week 8

Step Length of Gait at preferred pace

Variables: Step Length (m)

Time frame: baseline

Step Length of Gait at preferred pace

Variables: Step Length (m)

Time frame: at week 8

Speed during Dual task gait

Variables: Speed (m/s)

Time frame: baseline

Speed during Dual task gait

Variables: Speed (m/s)

Time frame: at week 8

Cadence during Dual task gait

Variables: cadence (steps/min)

Time frame: Baseline

Cadence during Dual task gait

Variables: cadence (steps/min)

Time frame: at week 8

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.